Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001880269 | SCV002163904 | uncertain significance | not provided | 2021-08-07 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals with ELP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 990664). This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with phenylalanine at codon 298 of the ELP1 protein (p.Ser298Phe). The serine residue is highly conserved and there is a large physicochemical difference between serine and phenylalanine. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV005040125 | SCV005674615 | uncertain significance | Medulloblastoma; Familial dysautonomia | 2024-02-04 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001278729 | SCV001465761 | uncertain significance | Familial dysautonomia | 2020-08-14 | no assertion criteria provided | clinical testing |